No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN)

European Journal of Cancer

Volumn 46, Issue 3, 2010, Pages 476-478

  Farante, Gabriel ^a   Galimberti, Viviana ^a   Zurrida, Stefano ^a,b   Veronesi, Paolo ^a,b   Luini, Alberto ^a   Veronesi, Umberto ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Axillary dissection; Breast cancer; Ductal intraepithelial neoplasia

Indexed keywords

TAMOXIFEN;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; DUCTAL INTRAEPITHELIAL NEOPLASIA; HIGH RISK POPULATION; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; MICROMETASTASIS; NEOPLASM; PATHOGENESIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; UNITED KINGDOM; UNITED STATES;

AXILLA; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPH NODE EXCISION; SENTINEL LYMPH NODE BIOPSY; UNNECESSARY PROCEDURES;

EID: 75149179998     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.12.004     Document Type: Article

References (25)

1. Leonard G., and Swain S. Ductal Carcinoma in situ, complexities and challenges. J Natl Cancer Inst 96 (2004) 906-920
2. Winchester D.P., Menck H.R., Osteen R.T., et al. Treatment trends for ductal carcinoma in situ of the breast. Ann Surg Oncol 2 (1995) 207-213
3. Porembka M., Abraham R.L., Sefko J.A., et al. Factors associated with lymph node assessment in DCIS: analysis of 1988-2002 Seer data. Ann Surg Oncol 15 (2008) 2709-2719
4. Bishop H, Kearins O, Lawrence G et al. Significant Variation in the management of non invasive breast carcinoma in the UK: Initial findings from the Sloane Project, a UK National Prospective Audit. In: Proceedings of the 9th Annual Meeting of the American Society of Breast Surgeons. April 30-May 4; 2008. p 31.
5. Morrow M. Axillary surgery in DCIS: is less more?. Ann Surg Oncol 15 (2008) 2641-2642
6. Veronesi U., Paganelli G., and Viale G. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 91 (1999) 368-373
7. Burstein H.J., Polyak K., Wong J.S., et al. Ductal carcinoma in situ of the breast. N Engl J Med 350 (2004) 1430-1441
8. Pendas S., Dauway E., Giuliano R., et al. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 7 (2000) 15-20
9. Ansari B., Ogston S.A., Purdie C.A., et al. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg 95 (2008) 547-554
10. Intra M., Veronesi P., and Mazzarol G. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138 (2003) 309-313
11. Cody H.S. Sentinel lymph node biopsy for breast cancer: indications, contraindications, and new directions. J Surg Oncol 95 (2007) 440-442
12. Julian T.B., Land S.R., Fourchette V., et al. Is sentinel node biopsy necessary in conservately treated DCIS?. Ann Surg Oncol 14 (2007) 2202-2208
13. Yi M., Krishnamurthy S., Kuerer H.M., et al. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 196 (2008) 81-87
14. Dominguez F., Golshan M., Black D., et al. SLN biopsy is important in mastectomy for DCIS. Ann Surg Oncol 15 (2008) 268-273
15. Intra M., Rotmentz N., Mattar D., et al. Unnecessary axillary node dissections in the sentinel lymph node era. Eur J Cancer 43 (2007) 2664-2668
16. Mittendorf E.A., Arciero C.A., Guttchell V., et al. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg 62 (2005) 253-257
17. El Sayed M.E., Rakha W.A., Reed J., et al. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Hystopathology 53 (2008) 650-657
18. Sakr F.A., Bezu R., Raoust C., et al. The sentinel lymph node procedure for patients with preoperative diagnosis of ductal carcinoma in situ: risk factors for unsuspected invasive disease and for metastatic sentinel lymph nodes. Int J Clin Practice 62 (2008) 1730-1735
19. Yen T.W., Hunt K.K., Ross M.I., et al. Predictors of invasive breast cancer of an initial diagnosis of DCIS. A guide in the selective use of sentinel lymph node biopsy in management of DCIS. J Am Coll Surg 200 (2005) 516-526
20. O'Flynn E.A., Morel J.C., Gonzales J., et al. Prediction of the presence of invasive disease from the measurement of extent of malignant micro-calcifications on mammography and ductal carcinoma in situ grade at core biopsy. Clinical Radiology 64 (2009) 178-183
21. Murphy C.D., Jones J.L., Hughes Javid S., et al. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?. Am J Surg 196 (2008) 566-568
22. Moore K., Sweeney K., Wilson M., et al. Ann Surg Oncol 14 (2007) 2911-2917
23. Tunon-de-Lara C., Giard S., Buttarelli M., et al. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma treated by mastectomy. SO Breast J 14 (2008) 135-140
24. Leidenius M., Salmenkivi K., von Smitten K., et al. Tumour-positive sentinel node findings in patients with ductal carcinoma in situ. J Surg Oncol 94 (2006) 380-384
25. NIH State-of-the-Science Conference Statement. Diagnosis and management of DCIS. September 22-24; 2009.